The Rb/E2F pathway and cancer
- PMID: 11257102
- DOI: 10.1093/hmg/10.7.699
The Rb/E2F pathway and cancer
Abstract
Over the past decade, studies focusing on the mechanisms controlling cellular proliferation have converged with equally intensive efforts directed at the analysis of oncogenic pathways associated with human cancer. These convergent studies have revealed the central role played by the pathway that controls the activity of the retinoblastoma tumor suppressor protein (Rb), which in turn regulates the E2F transcription factor. In particular, it is now clear that the Rb/E2F pathway is critical in regulating the initiation of DNA replication. It is also clear that the control of the pathway is disrupted in virtually all human cancers. Questions remain, however, as to the specific role played by individual activities within the pathway in the control of cell growth and their participation in the development of cancer.
Comment in
-
Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?Oncotarget. 2014 Jan 15;5(1):5-6. doi: 10.18632/oncotarget.1710. Oncotarget. 2014. PMID: 24371157 Free PMC article. No abstract available.
Similar articles
-
Role of the Rb/E2F pathway in cell growth control.J Cell Physiol. 1997 Nov;173(2):233-6. doi: 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F. J Cell Physiol. 1997. PMID: 9365528 Review. No abstract available.
-
The cell cycle-regulating transcription factors E2F-RB.Br J Cancer. 1999 Jul;80 Suppl 1:38-41. Br J Cancer. 1999. PMID: 10466760 Review. No abstract available.
-
Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.Oncogene. 1999 Jun 10;18(23):3501-10. doi: 10.1038/sj.onc.1202684. Oncogene. 1999. PMID: 10376528
-
Retinoblastoma protein in growth suppression and death protection.Curr Opin Genet Dev. 1997 Feb;7(1):39-45. doi: 10.1016/s0959-437x(97)80107-4. Curr Opin Genet Dev. 1997. PMID: 9024632 Review.
-
The Rb/chromatin connection and epigenetic control: opinion.Oncogene. 2001 May 28;20(24):3128-33. doi: 10.1038/sj.onc.1204337. Oncogene. 2001. PMID: 11420729 Review.
Cited by
-
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.Front Immunol. 2023 Nov 2;14:1285113. doi: 10.3389/fimmu.2023.1285113. eCollection 2023. Front Immunol. 2023. PMID: 38022620 Free PMC article. Review.
-
Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice.Oncotarget. 2020 Jul 14;11(28):2718-2739. doi: 10.18632/oncotarget.27660. eCollection 2020 Jul 14. Oncotarget. 2020. PMID: 32733644 Free PMC article.
-
Leveraging metabolic modeling and machine learning to uncover modulators of quiescence depth.PNAS Nexus. 2024 Jan 12;3(1):pgae013. doi: 10.1093/pnasnexus/pgae013. eCollection 2024 Jan. PNAS Nexus. 2024. PMID: 38292544 Free PMC article.
-
Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.Mol Cell Biol. 2004 Nov;24(21):9527-41. doi: 10.1128/MCB.24.21.9527-9541.2004. Mol Cell Biol. 2004. PMID: 15485920 Free PMC article.
-
Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis.Mol Endocrinol. 2005 Sep;19(9):2371-9. doi: 10.1210/me.2005-0137. Epub 2005 May 26. Mol Endocrinol. 2005. PMID: 15919720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous